BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37130578)

  • 21. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation.
    Ohira T; Nishio K; Ohe Y; Arioka H; Nishio M; Funayama Y; Ogasawara H; Fukuda M; Yazawa K; Kato H; Saijo N
    J Cancer Res Clin Oncol; 1996; 122(12):711-5. PubMed ID: 8954167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
    Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
    Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.
    Pötsch MS; Ishida J; Palus S; Tschirner A; von Haehling S; Doehner W; Anker SD; Springer J
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):594-605. PubMed ID: 32067370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concurrent treatment of Scutellaria baicalensis Georgi enhances the therapeutic efficacy of cisplatin but also attenuates chemotherapy-induced cachexia and acute kidney injury.
    Huang TH; Wu TH; Guo YH; Li TL; Chan YL; Wu CJ
    J Ethnopharmacol; 2019 Oct; 243():112075. PubMed ID: 31291609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
    Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
    Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
    Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
    Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
    Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
    Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
    Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of skeletal muscle fibrosis in a rodent model of cancer cachexia.
    Washington TA; Schrems ER; Haynie WS; Rosa-Caldwell ME; Brown JL; Saling L; Lim S; Perry RA; Brown LA; Lee DE; Greene NP
    Cell Biochem Funct; 2023 Jun; 41(4):478-489. PubMed ID: 37150891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
    Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer.
    Ando K; Takahashi F; Kato M; Kaneko N; Doi T; Ohe Y; Koizumi F; Nishio K; Takahashi K
    PLoS One; 2014; 9(7):e102436. PubMed ID: 25010770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.
    Martin A; Castells J; Allibert V; Emerit A; Zolotoff C; Cardot-Ruffino V; Gallot YS; Vernus B; Chauvet V; Bartholin L; Schaeffer L; Durieux AC; Hourdé C; Favier FB; Mazelin L; Freyssenet D
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1686-1703. PubMed ID: 35277933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling.
    Straughn AR; Kakar SS
    J Ovarian Res; 2019 Nov; 12(1):115. PubMed ID: 31767036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.
    Morena da Silva F; Lim S; Cabrera AR; Schrems ER; Jones RG; Rosa-Caldwell ME; Washington TA; Murach KA; Greene NP
    BMC Genomics; 2023 Jul; 24(1):374. PubMed ID: 37403010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
    Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.